ASR Vermogensbeheer’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
ASR Vermogensbeheer's REGN Position: Q2 2026 in Review
ASR Vermogensbeheer increased its Regeneron Pharmaceuticals (REGN) stake by 72% in Q2 2026, buying an estimated $4.32M and bringing the position to 15,098 shares worth $9.41M. The position accounts for 0.1% of the portfolio, ranked #199.
ASR Vermogensbeheer first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- ASR Vermogensbeheer held 15,098 shares of Regeneron Pharmaceuticals worth $9.41M as of Q2 2026.
- ASR Vermogensbeheer bought 6,343 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.32M.
- Regeneron Pharmaceuticals made up 0.1% of ASR Vermogensbeheer's portfolio in Q2 2026, its #199 holding.
- ASR Vermogensbeheer first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.